Zobrazeno 1 - 5
of 5
pro vyhledávání: '"O. A. Sutochnikova"'
Autor:
S. YA. Loginova, S. V. Borisevich, V. N. Shchukina, M. V. Lykov, G. V. Borisevich, V. P. Bondarev, V. E. Nebolsin, O. A. Sutochnikova, A. G. Chychalin
Publikováno v:
Антибиотики и Химиотерапия, Vol 55, Iss 11-12, Pp 17-21 (2020)
High in vitro and in vivo efficacy of Ingavirin® against the Mexican pandemic influenza virus A/H1N1/2009, strains A/California/ 04/2009 (H1N1) and A/California/07/2009 (H1N1) vs. the reference drug Arbidol® was studied and verified when used thera
Externí odkaz:
https://doaj.org/article/76fa6a90c064433cab7ae2246e1d2993
Autor:
D K Lvov, L V Kolobukhina, E I Burtseva, I S Kruzhkova, N A Malyshev, I T Fedyakina, E S Kirillova, S V Trushakova, E L Feodoritova, L N Merkulova, K G Krasnoslobodtsev, Е A Mukasheva, E O Garina, R V Vartanyan, L B Kisteneva, A G Prilipov, M V Bazarova, A V Devyatkin, O A Sutochnikova
Publikováno v:
Терапевтический архив, Vol 88, Iss 11, Pp 112-120 (2016)
In the 2015—2016 epidemic season, there were dominant influenza A(H1N1)pdm09 strains (over 90%) among the circulating influenza viruses in most countries of the Northern Hemisphere and in Russia. A study of the antigenic properties of influenza A(H
Externí odkaz:
https://doaj.org/article/b6c6c360ab494fa994838bb5dd5f7d9d
Autor:
L V Kolobukhina, E I Burtseva, M Iu Shchelkanov, S V Al'khovskiĭ, A G Prilipov, L N Merkulova, L B Kisteneva, R V Vartanian, I S Kruzhkova, S V Trushakova, K G Krasnoslobovtsev, S N Avdeev, O A Sutochnikova, M V Bazarova, E I Kelli, O E Ambrosi, N A Malyshev, D K L'vov, A G Chuchalin
Publikováno v:
Терапевтический архив, Vol 86, Iss 10, Pp 52-59 (2014)
AIM. To characterize the 2013-2014 epidemic season from the results of detection of influenza infection in patients; to provide the molecular genetic characteristics of the strains isolated from deceased patients. MATERIALS AND METHODS. The investiga
Externí odkaz:
https://doaj.org/article/f6d06c11c9b3464ba8eb45827e1d5fbf
Autor:
Lyudmila Vasil'evna Kolobukhina, L N Merkulova, M Yu Shchelkanov, E I Burtseva, V V Lavrishcheva, E I Samokhvalov, S V Al'khovskiy, A G Prilipov, E S Proshina, S N Avdeev, O A Sutochnikova, M V Bazarova, E I Kelli, N D Tserukalova, I A Blank, O M Shestakova, O N Kolivashko, T V Arseneva, O E Ambrosi, A A Shul'dyakov, A F Popov, A I Simakova, N A Malyshev, A G Chuchalin, D K L'vov, L V Kolobukhina, M Yu Schelkanov, V V Lavrischeva, S V Alkhovsky, A A Shuldyakov, D K Lvov
Publikováno v:
Терапевтический архив, Vol 83, Iss 9, Pp 48-53 (2011)
Aim. To assess efficacy and safety of ingavirin in the treatment of the flu caused by pandemic virus of flu A (H1N1) sw1 in hospitalized patients compared with oseltamivir. Material and methods. A population-based comparative multicenter trial includ
Externí odkaz:
https://doaj.org/article/9881f5d23fa943a9a3842a63b0d5b0e3
Autor:
O A, Sutochnikova, M V, Samsonova, A V, Cherniak, A L, Cherniaev, A S, Sokolov, A G, Chuchalin
Publikováno v:
Terapevticheskii arkhiv. 68(3)
11 patients with severe bronchial asthma entered a randomized trial of glucocorticosteroid budesonide of Russian produce. Of them 6 patients received inhalations of budesonide (800 micrograms/day for 6 months), 5 control patients did not receive the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7aacd104d374f507fab757c55bb81c1d
https://pubmed.ncbi.nlm.nih.gov/8744104
https://pubmed.ncbi.nlm.nih.gov/8744104